Literature DB >> 15237006

Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.

Petra Bourdrez1, Marlies Y Bongers, Ben W J Mol.   

Abstract

OBJECTIVE: To investigate patient preferences for endometrial ablation and a levonorgestrel-releasing intrauterine device (IUD) as alternatives to hysterectomy in the treatment of dysfunctional uterine bleeding.
DESIGN: Comparative study based on structured interviews.
SETTING: A large teaching hospital with 500 beds in the Netherlands. PATIENT(S): Ninety-six patients who were scheduled for endometrial ablation, 25 patients who were scheduled for hysterectomy, and 23 patients who were scheduled for a levonorgestrel-releasing IUD were interviewed. All of the women had dysfunctional uterine bleeding. INTERVENTION(S): Patients were asked to state their most significant complaints and their reasons for choosing a particular treatment. Subsequently, the preference for endometrial ablation and a levonorgestrel-releasing IUD as alternatives to hysterectomy was assessed during a structured interview. Women were informed about the advantages and disadvantages of all three treatment options. Patients rated their preferences according to different hypothetical success rates. The success rates after endometrial ablation and levonorgestrel-releasing IUD were varied until patients found an acceptable treatment outcome. MAIN OUTCOME MEASURE(S): Patient preference of endometrial ablation and the levonorgestrel-releasing IUD over hysterectomy. RESULT(S): The main reason for the treatment of choice differed between the three groups. Most of the patients in the hysterectomy group wanted a definite solution to their problems, whereas patients in the levonorgestrel-releasing IUD group and in the ablation group put greater emphasis on a minimally invasive intervention with or without a short hospital stay. In women undergoing ablation, 70% of the patients preferred this treatment and the levonorgestrel-releasing IUD to hysterectomy in cases in which the success rate of noninvasive treatment was presumed to be 50%. In women having a levonorgestrel-releasing IUD inserted, 95% of the patients preferred this approach over hysterectomy in cases in which the success rate of this device was presumed to be 50%, whereas 35% of patients preferred ablation over hysterectomy in cases in which the success rate of ablation was presumed to be 50%. In women undergoing hysterectomy, 30% would have opted for ablation and 45% would have opted for a levonorgestrel-releasing IUD in cases in which success rates were 50%. Of patients who opted for hysterectomy, however, 60% stated that they would have preferred a noninvasive treatment if the success rate of this type of treatment were >80%. CONCLUSION(S): A majority of the patients who had dysfunctional uterine bleeding and who were scheduled for an endometrial ablation or a levonorgestrel-releasing IUD were inclined to take a risk of 50% likelihood of treatment failure to avoid a hysterectomy. As a consequence, research of treatment for dysfunctional uterine bleeding should focus on this 50% success level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237006     DOI: 10.1016/j.fertnstert.2003.12.025

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.

Authors:  Rosalie J Fergusson; Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-08-29

Review 2.  Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-11-01

3.  Experimental study of destruction to porcine spleen in vivo by microwave ablation.

Authors:  Fei Gao; Yang-Kui Gu; Jing-Xian Shen; Chang-Lun Li; Xiong-Ying Jiang; Jin-Hua Huang
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

4.  Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.

Authors:  Tamara J Oderkerk; Pleun Beelen; Peggy M A J Geomini; Malou C Herman; Jaklien C Leemans; Ruben G Duijnhoven; Judith E Bosmans; Justine N Pannekoek; Thomas J Clark; Ben Willem J Mol; Marlies Y Bongers
Journal:  BMC Womens Health       Date:  2022-06-27       Impact factor: 2.742

5.  Women's preference for laparoscopic or abdominal hysterectomy.

Authors:  Kirsten B Kluivers; Brent C Opmeer; Peggy M Geomini; Marlies Y Bongers; Mark E Vierhout; Gérard L Bremer; Ben W J Mol
Journal:  Gynecol Surg       Date:  2008-12-16

6.  Hysterectomy or a minimal invasive alternative? A systematic review on quality of life and satisfaction.

Authors:  H A M Brölmann; A J Bijdevaate; A Vonk Noordegraaf; P F Janssen; J A F Huirne
Journal:  Gynecol Surg       Date:  2010-05-22

7.  Prediction of treatment outcomes after global endometrial ablation.

Authors:  Sherif A El-Nashar; Matthew R Hopkins; Douglas J Creedon; Jennifer L St Sauver; Amy L Weaver; Michaela E McGree; William A Cliby; Abimbola O Famuyide
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

8.  Tactile Electrosurgical Ablation: A Technique for the Treatment of Intractable Heavy and Prolonged Menstrual Bleeding.

Authors:  Ali M El Saman; Faten F AbdelHafez; Kamal M Zahran; Hazem Saad; Mohamed Khalaf; Mostafa Hussein; Ibrahim M A Hassanin; Saba M Shugaa Al Deen
Journal:  Minim Invasive Surg       Date:  2015-07-30

9.  Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Rosalie J Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

10.  Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: a retrospective analysis with German health claims data.

Authors:  Christoph Bischoff-Everding; Ruediger Soeder; Benno Neukirch
Journal:  Int J Womens Health       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.